Targeting senescent cells to improve outcomes for breast cancer patients
Active Project Grant Awarded Last action
- Award ID
- HT94252410262
- Recipient
-
University Of Melbourne UEI P8JJC89CWNK5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $4,319,388
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 55% complete
- Place of performance
- Australia
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded a $4,319,388 Project Grant to the University of Melbourne to fund research aimed at "TARGETING SENESCENT CELLS TO IMPROVE OUTCOMES FOR BREAST CANCER PATIENTS" over the period from September 1, 2024 to August 31, 2028. This grant is provided under the Military Medical Research and Development Program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The University of Melbourne has a history of conducting federal grant-funded research in areas such as cancer, neurological disorders, and traumatic injuries. Past grant collaborators have included institutions like Washington University in St. Louis and St. Jude Children's Research Hospital.
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| The Walter And Eliza Hall Institute Of Medical Research | $331,148 |
Quick answers
Who received award HT94252410262?
HT94252410262 was awarded to University Of Melbourne by Defense Health Agency (Department of Defense) on September 1, 2024.
How much is award HT94252410262 worth?
$4,319,388 has been obligated on HT94252410262.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award